(Circulation. 2000;102:793.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Department of Medicine (Cardiology), Duke University Medical Center, Durham, NC, and the Department of Immunology, Universitätskliniken, Göttingen, Germany (M.O.).
Correspondence to Neil J. Freedman, MD, Box 3187, Duke University Medical Center, Durham, NC 27710. E-mail neil.freedman{at}duke.edu
BackgroundNeointimal hyperplasia involves activation of smooth muscle cells (SMCs) by several G proteincoupled receptor (GPCR) agonists, including endothelin-1, angiotensin II, thrombin, and thromboxane A2. Signaling of many GPCRs is diminished by GPCR kinase-2 (GRK2). We therefore tested whether overexpression of GRK2 in SMCs could diminish mitogenic signaling elicited by agonists implicated in the pathogenesis of neointimal hyperplasia.
Methods and ResultsOverexpression of GRK2 was achieved in primary rabbit aortic SMCs with a recombinant adenovirus. Control SMCs were infected with an empty vector adenovirus. Inositol phosphate responses to endothelin-1, angiotensin II, thrombin agonist peptide, and platelet-derived growth factor (PDGF) were attenuated by 37% to 72% in GRK2-overexpressing cells (P<0.01), but the response to the thromboxane A2 analogue U46619 was unaffected. GRK2 also inhibited SMC [3H]thymidine incorporation stimulated not only by these agonists (by 30% to 60%, P<0.01) but also by 10% FBS (by 35%, P<0.05). However, GRK2 overexpression had no effect on epidermal growth factorinduced [3H]thymidine incorporation. Agonist-induced tyrosine phosphorylation of the PDGF-ß receptor, but not the epidermal growth factor receptor, was reduced in GRK2-overexpressing SMCs. GRK2 overexpression also reduced SMC proliferation in response to endothelin-1, PDGF, and 10% FBS by 62%, 51%, and 29%, respectively (P<0.01), without any effect on SMC apoptosis.
ConclusionsGRK2 overexpression diminishes SMC mitogenic signaling and proliferation stimulated by PDGF or agonists for several GPCRs. Gene transfer of GRK2 may therefore be therapeutically useful for neointimal hyperplasia.
Key Words: muscle, smooth cells signal transduction receptors
This article has been cited by other articles:
![]() |
G. E. Morris, C. P. Nelson, N. B. Standen, R.A. J. Challiss, and J. M. Willets Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2 Cardiovasc Res, October 6, 2009; (2009) cvp310v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3072 - H3079. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Vinge, K. W. Andressen, T. Attramadal, G. O. Andersen, M. S. Ahmed, K. Peppel, W. J. Koch, N. J. Freedman, F. O. Levy, T. Skomedal, et al. Substrate Specificities of G Protein-Coupled Receptor Kinase-2 and -3 at Cardiac Myocyte Receptors Provide Basis for Distinct Roles in Regulation of Myocardial Function Mol. Pharmacol., September 1, 2007; 72(3): 582 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Wu, R. Goswami, X. Cai, S. T. Exum, X. Huang, L. Zhang, L. Brian, R. T. Premont, K. Peppel, and N. J. Freedman Regulation of the Platelet-derived Growth Factor Receptor-beta by G Protein-coupled Receptor Kinase-5 in Vascular Smooth Muscle Cells Involves the Phosphatase Shp2 J. Biol. Chem., December 8, 2006; 281(49): 37758 - 37772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Wu, R. Goswami, L. K. Kim, W. E. Miller, K. Peppel, and N. J. Freedman The Platelet-derived Growth Factor Receptor-{beta} Phosphorylates and Activates G Protein-coupled Receptor Kinase-2: A MECHANISM FOR FEEDBACK INHIBITION J. Biol. Chem., September 2, 2005; 280(35): 31027 - 31035. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Peppel, L. Zhang, E. S. Orman, P.-O. Hagen, A. Amalfitano, L. Brian, and N. J. Freedman Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms Cardiovasc Res, February 15, 2005; 65(3): 674 - 682. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. Peppel, L. Brian, L. Chien, and N. J. Freedman Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic Cells Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2277 - 2283. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Hildreth, J.-H. Wu, L. S. Barak, S. T. Exum, L. K. Kim, K. Peppel, and N. J. Freedman Phosphorylation of the Platelet-derived Growth Factor Receptor-{beta} by G Protein-coupled Receptor Kinase-2 Reduces Receptor Signaling and Interaction with the Na+/H+ Exchanger Regulatory Factor J. Biol. Chem., October 1, 2004; 279(40): 41775 - 41782. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, N. J. Freedman, L. Brian, and K. Peppel Graft-Extrinsic Cells Predominate in Vein Graft Arterialization Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 470 - 476. [Abstract] [Full Text] |
||||
![]() |
A. L. Bookout, A. E. Finney, R. Guo, K. Peppel, W. J. Koch, and Y. Daaka Targeting G{beta}{gamma} Signaling to Inhibit Prostate Tumor Formation and Growth J. Biol. Chem., September 26, 2003; 278(39): 37569 - 37573. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Freedman, L. K. Kim, J. P. Murray, S. T. Exum, L. Brian, J.-H. Wu, and K. Peppel Phosphorylation of the Platelet-derived Growth Factor Receptor-beta and Epidermal Growth Factor Receptor by G Protein-coupled Receptor Kinase-2. MECHANISMS FOR SELECTIVITY OF DESENSITIZATION J. Biol. Chem., December 6, 2002; 277(50): 48261 - 48269. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology Circ. Res., May 25, 2001; 88(10): 987 - 997. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |